IRF2BP2 and acute myeloid leukemia: Further research revealed that the anti‐inflammatory effect mediated by IRF2BP2 in AML depends on the AP‐1 heterodimer composed of ATF7 and JDP2.[44] Our previous studies in neuroblastoma have shown that IRF2BP2 is driven by SE, leading to significantly elevated expression levels.